BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 20193639)

  • 1. Antioxidant drugs for treating beta-cell oxidative stress in type 2 diabetes: glucose-centric versus insulin-centric therapy.
    Robertson RP
    Discov Med; 2010 Feb; 9(45):132-7. PubMed ID: 20193639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection of pancreatic beta-cells: is it feasible?
    Bonora E
    Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):74-83. PubMed ID: 18096375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of oxidative stress by a new low-molecular-weight antioxidant improves metabolic alterations in a nonobese mouse diabetes model.
    Novelli M; D'Aleo V; Lupi R; Paolini M; Soleti A; Marchetti P; Masiello P
    Pancreas; 2007 Nov; 35(4):e10-7. PubMed ID: 18090226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-cell function and mass in type 2 diabetes.
    Larsen MO
    Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes, glucose toxicity, and oxidative stress: A case of double jeopardy for the pancreatic islet beta cell.
    Robertson RP; Harmon JS
    Free Radic Biol Med; 2006 Jul; 41(2):177-84. PubMed ID: 16814095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative stress--mediated alterations in glucose dynamics in a genetic animal model of type II diabetes.
    Bitar MS; Al-Saleh E; Al-Mulla F
    Life Sci; 2005 Sep; 77(20):2552-73. PubMed ID: 15936776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Oxidative stress and its effects on insulin resistance and pancreatic beta-cells dysfunction: relationship with type 2 diabetes mellitus complications].
    Lopes JP; Oliveira SM; Soares Fortunato J
    Acta Med Port; 2008; 21(3):293-302. PubMed ID: 18674421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutathione peroxidase 3 mediates the antioxidant effect of peroxisome proliferator-activated receptor gamma in human skeletal muscle cells.
    Chung SS; Kim M; Youn BS; Lee NS; Park JW; Lee IK; Lee YS; Kim JB; Cho YM; Lee HK; Park KS
    Mol Cell Biol; 2009 Jan; 29(1):20-30. PubMed ID: 18936159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative reactive species in cell injury: Mechanisms in diabetes mellitus and therapeutic approaches.
    Fridlyand LE; Philipson LH
    Ann N Y Acad Sci; 2005 Dec; 1066():136-51. PubMed ID: 16533924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary antioxidants and glucose metabolism.
    Franzini L; Ardigò D; Zavaroni I
    Curr Opin Clin Nutr Metab Care; 2008 Jul; 11(4):471-6. PubMed ID: 18542009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluoride exposure impairs glucose tolerance via decreased insulin expression and oxidative stress.
    García-Montalvo EA; Reyes-Pérez H; Del Razo LM
    Toxicology; 2009 Sep; 263(2-3):75-83. PubMed ID: 19540901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased glucose uptake promotes oxidative stress and PKC-delta activation in adipocytes of obese, insulin-resistant mice.
    Talior I; Yarkoni M; Bashan N; Eldar-Finkelman H
    Am J Physiol Endocrinol Metab; 2003 Aug; 285(2):E295-302. PubMed ID: 12857675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress.
    Rolo AP; Palmeira CM
    Toxicol Appl Pharmacol; 2006 Apr; 212(2):167-78. PubMed ID: 16490224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The emerging role of FOXO transcription factors in pancreatic beta cells.
    Glauser DA; Schlegel W
    J Endocrinol; 2007 May; 193(2):195-207. PubMed ID: 17470511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta testing the antioxidant function of eIF2alpha phosphorylation in diabetes prevention.
    Wek RC; Anthony TG
    Cell Metab; 2009 Jul; 10(1):1-2. PubMed ID: 19583945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fate of the beta-cell in the pathophysiology of type 2 diabetes.
    Campbell RK
    J Am Pharm Assoc (2003); 2009; 49 Suppl 1():S10-5. PubMed ID: 19801360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current issues in the treatment of type 2 diabetes. Overview of newer agents: where treatment is going.
    DeFronzo RA
    Am J Med; 2010 Mar; 123(3 Suppl):S38-48. PubMed ID: 20206731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Insulin resistance and oxidative stress].
    Andreeva-Gateva P
    Vutr Boles; 1999; 31(4):9-19. PubMed ID: 10989670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute hyperglycemia and oxidative stress: direct cause and effect?
    Choi SW; Benzie IF; Ma SW; Strain JJ; Hannigan BM
    Free Radic Biol Med; 2008 Apr; 44(7):1217-31. PubMed ID: 18226604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonobese, insulin-deficient Ins2Akita mice develop type 2 diabetes phenotypes including insulin resistance and cardiac remodeling.
    Hong EG; Jung DY; Ko HJ; Zhang Z; Ma Z; Jun JY; Kim JH; Sumner AD; Vary TC; Gardner TW; Bronson SK; Kim JK
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1687-96. PubMed ID: 17911348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.